This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2012 Mar 14;307(10):1024; author reply 1024-5.

doi: 10.1001/jama.2012.281.

Clopidogrel dosing based on genotype

Dimitrios Alexopoulos, Ioanna Xanthopoulou

PMID: 22416093
DOI: 10.1001/jama.2012.281

Comment

Clopidogrel dosing based on genotype

Dimitrios Alexopoulos et al. JAMA. 2012.

. 2012 Mar 14;307(10):1024; author reply 1024-5.

doi: 10.1001/jama.2012.281.

Authors

Dimitrios Alexopoulos, Ioanna Xanthopoulou

PMID: 22416093
DOI: 10.1001/jama.2012.281

No abstract available

PubMed Disclaimer

Comment on

Dosing clopidogrel based on CYP2C19 genotype and the effect on platelet reactivity in patients with stable cardiovascular disease.
Mega JL, Hochholzer W, Frelinger AL 3rd, Kluk MJ, Angiolillo DJ, Kereiakes DJ, Isserman S, Rogers WJ, Ruff CT, Contant C, Pencina MJ, Scirica BM, Longtine JA, Michelson AD, Sabatine MS. Mega JL, et al. JAMA. 2011 Nov 23;306(20):2221-8. doi: 10.1001/jama.2011.1703. Epub 2011 Nov 16. JAMA. 2011. PMID: 22088980 Clinical Trial.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Silverchair Information Systems
Medical
- MedlinePlus Health Information